Impulse Dynamics announced today that it raised $136 million in financing to accelerate its investment in its heart failure therapy. Perceptive Advisors, Redmile Group, Alger and Hobart Healthcare led the financing round. The company expects it to accelerate investment in global commercialization, technology, product innovation and clinical evidence development. Marlton, New Jersey–based Impulse Dynamics plans […]
Funding Roundup
Procyrion raises $57.7M Series E for circulatory support device
Procyrion announced today that it completed a $57.7 million Series E funding round to support its Aortix device. Fannin Partners led the round, which included the conversion of $10 million in interim financing. New and existing family/multi-family office investors partnered with Fannin Partners in the financing. Returning investors, including BlueBird Ventures and an undisclosed strategic […]
ReWalk Robotics looks to the future following Lifeward rebrand
On Jan. 29, ReWalk Robotics announced a rebrand to “Lifeward.” The rebrand had, in many ways, been in the works for about six months. Really, though, Lifeward CEO Larry Jasinski started formulating this plan a few years ago. All it needed was a few key ingredients to propel the physical rehabilitation and recovery company forward. […]
Fractyl Health goes the IPO route
Fractyl Health — developer of medtech and gene therapies to reverse diabetes and obesity — began trading on the Nasdaq today under the symbol GUTS. Lexington, Massachusetts–based Fractyl Health priced its 7,333,333 shares of common stock at $15 per share, enabling it to bring in about $110 million from the IPO. The company expected the […]
Avation Medical raises $22M for closed-loop wearable neuromod tech
Avation Medical announced today that it raised $22 million in a Series C financing round to support its wearable peripheral neuromodulation technology. New investors ShangBay Capital and Asahi Kasei led the round. Other new investors included Angelini Ventures, JobsOhio Growth Capital Fund and more. Existing investors Arboretum Ventures, Tonkawa, Medtronic and Avestria Ventures participated, too. […]
Abbott enters into new $5B credit facility
Abbott announced that it entered into a five-year credit agreement worth up to $5 billion on an unsecured basis. The company entered into the agreement with lenders from time to time party thereto and JPMorgan Chase Bank as administrative agent. According to an SEC filing, the agreement gives Abbott the ability to borrow up to […]
RenovoRx closes $6.1M private placement
RenovoRx announced today that it closed a private placement bringing in gross proceeds of approximately $6.1 million. Los Altos, California-based RenovoRx develops precision oncology therapies based on a local drug delivery platform. Closing this funding round extends the company’s cash runway as it conducts its pivotal TIGer-PaC Phase III clinical trial. It expects the funds […]
Insulet enters into new credit agreement worth $487.5M in term loans
Insulet announced that it entered into an amended credit agreement to replace existing term loans. The automated insulin delivery technology developer entered into the agreement with Morgan Stanley Senior Funding. This agreement amended a credit agreement dated May 4, 2021. Pursuant to the agreement, the $487.5 million in term loans outstanding under the existing agreement […]
Sight Sciences closes $65M credit facility
Sight Sciences (Nasdaq:SGHT) announced that it closed a senior secured credit facility worth up to $65 million. The credit facility with Hercules Capital includes the immediate draw of $35 million. Menlo Park, California–based Sight Sciences used the proceeds to pay off the principal amount of debt to its previous secured lender. In addition to the […]
Motif Neurotech raises $18.75M Series A for miniature brain pacemaker
Motif Neurotech announced today that it brought in a Series A financing round worth proceeds of $18.75 million. Arboretum Ventures led the financing with new investors KdT Ventures, Satori Neuro, Dolby Family Ventures and re.Mind Capital participating. Existing investors Divergent Capital, TMC Innovation, PsyMed Ventures, Empath Ventures and Capital Factory contributed as well. The company […]
Heart failure startup Acorai closes $4.5M funding round
Acorai announced today closed an oversubscribed seed equity funding round worth proceeds totaling more than $4.5 million. Helsingborg, Sweden-based Acorai develops a first-of-its-kind device aimed to improve heart failure management. The non-invasive intracardiac pressure monitoring device aims to improve heart failure management. It received FDA breakthrough device designation in August following positive results from a […]